GetTopicDetailResponse(id=d14d2430486, topicName=亞組分析, introduction=亞組分析, content=null, image=null, comments=0, allHits=698, url=https://h5.medsci.cn/topic?id=24304, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=28641, tagList=[TagDto(tagId=28641, tagName=亞組分析)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2250072, encodeId=71a422500e220, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多發(fā)性骨髓瘤#</a> <a href='/topic/show?id=d14d2430486' target=_blank style='color:#2F92EE;'>#亞組分析#</a> <a href='/topic/show?id=7f389396e27' target=_blank style='color:#2F92EE;'>#達雷妥尤單抗#</a>, objectTitle=Leukemia | 達雷妥尤單抗聯(lián)合療法在未經(jīng)治療的多發(fā)性骨髓瘤中的顯著療效：MAIA研究的關鍵亞組分析, objectType=article, longId=861618, objectId=dbed8616183b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240604/1717465644811_92910.jpg, objectUrl=/article/show_article.do?id=dbed8616183b, replyNumber=0, likeNumber=59, createdTime=2025-01-31, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=dbed8616183b, moduleTitle=Leukemia | 達雷妥尤單抗聯(lián)合療法在未經(jīng)治療的多發(fā)性骨髓瘤中的顯著療效：MAIA研究的關鍵亞組分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=dbed8616183b)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
